Outset Medical Q2 FY26 net loss narrows to $18 million; revenue rises 1% to $31.6 million
OM•HCA Healthcare agreement
The company signed a three-year $40 million agreement with HCA Healthcare to refresh its Tablo fleet across the health system.
Full-year outlook reiterated
Outset Medical reiterated its 2026 revenue outlook of $125 million-$130 million and said it expects full-year non-GAAP gross margin in the low-40% to mid-40% range.
Q2 revenue, loss and margin improve
Outset Medical posted Q2 2026 revenue of $31.6 million, up 1% year over year and up 14% sequentially.
Net loss narrowed to $18 million; GAAP loss per share improved to $0.97.
Gross margin expanded 4.2 percentage points to 42% as gross profit rose 12% to $13.3 million.
Related News

ParkerVision FY26 H1 net loss narrows to $1.4 million; cash and cash equivalents total $2.5 million at June 30
PRKR•

Metalpha FY26 net profit drops 91.93% to US$ 1.28 million; revenue falls 16.68% to US$ 37.13 million
MATH•


